The BENeFiTS Trial in Beta Thalassemia Intermedia
The BENeFiTS Trial in Beta Thalassemia Intermedia
Enrolling by invitation · NCT04432623 · Registry updated 2025-08-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The BENeFiTS Trial in Beta Thalassemia Intermedia | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease, thalassemia | Enrolling by invitation | Phase 1 / Phase 2 | 2025-08-15 | NCT04432623 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| Phoenicia BioScience | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| Susan Perrine | Weston | United States | 1 |
| UCSF Benioff Children's Hospital at Oakland | Oakland | United States | 1 |
| University Health Network and Toronto General Hospital | Toronto | Canada | 1 |
| Weil Cornell Medicine | New York | United States | 1 |